Recurrent Status Epilepticus and SARS-CoV-2 infection: the “perfect storm”
Keywords:
status epilepticus, delirium, anti-seizure medications, EEG monitoring, SARS-CoV-2Abstract
Respiratory involvement is the most common clinical manifestation of COVID-19, but neurological symptoms and complications are increasingly being recognized. Seizures and status epilepticus (SE) have been described as possible consequences of hypoxia and metabolic derangements during SARS-CoV-2 infection, direct viral invasion of the central nervous system, or as para or post-infectious complications. Single episodes of SE have been described, occurring during the acute phase of COVID-19 or once the patients have been recovered.
Herein, we present the case of a patient with a positive serology test for SARS-CoV-2 (IgG+, IgM-) and recurrent SE occurring within 36 days. Diagnostic work-up ruled out other known causes of SE. A post-COVID-19 infectious inflammatory/immune response is hypothesized as the possible trigger of SE.
References
Ellul MA, Benjamin L, Singh B, et al. Neurological associations of COVID-19. Lancet 2020; 19(9): 767-83. Doi: 10.1016/S1474-4422(20)30221-0.
Deana C, Verriello L, Pauletto G, et al. Insights into neurological dysfunction of critically ill COVID-19 patients. Trends Anaesthesia Critic Care 2020; In press. Doi: 10.1016/j.tacc.2020.09.005.
Gigli GL, Vogrig A, Nilo A, et al. HLA and immunological features of SARS-CoV-2-induced Guillain-Barré syndrome. Neurol Sci 2020; 41(12): 3391-4. Doi: 10.1007/s10072-020-04787-7.
Carroll E, Neumann H, Aguero-Rosenfeld ME, et al. Post-COVID-19 inflammatory syndrome manifesting as refractory status epilepticus. Epilepsia 2020; 61(10): e135-e139. Doi: 10.1111/epi.16683.
Vollono C, Rollo E, Romozzi M, et al. Focal status epilepticus as unique clinical feature of COVID-19: a case report. Seizure 2020; 78: 109-112. Doi: 10.1016/j.seizure.2020.04.009.
Dono F, Carrarini C, Russo M, et al. New-onset refractory status epilepticus (NORSE) in post SARS-CoV-2 autoimmune encephalitis: a case report. Neurol Sci 2021; 42(1): 35-38. Doi: 10.1007/s10072-020-04846-z.
Chen W, Toprani S, Werbaneth K, Falco-Walter J. Status epilepticus and other EEG findings in patients with COVID-19: a case series. Seizure 2020; 81: 198-200. Doi: 10.1016/j.seizure.2020.08.022.
Somani S, Pati S, Gaston T, Chitlangia A, Agnihotri S. De novo status epilepticus in patients with COVID-19. Ann Clin Transl Neurol 2020; 7(7): 1240-4. Doi: 10.1002/can.3.51071.
Balloy G, Leclair-Visonneau L, Péréon Y, Magot A, Peyre A, Mahé PJ, et al. Non-lesional status epilepticus in a patient with coronavirus disease 2019. Clin Neurophysiol 2020; 131(8): 2059-61. Doi: 10.1016/j.clinph.2020.05.005.
Pilotto A, Odolini S, Masciocchi S, et al. Steroid-responsive encephalitis in coronavirus disease 2019. Ann Neurol 2020; 88(2): 423-7. Doi: 10.1002/ana.25783.
Arevalo-Rodriguez I, Buitrago-Garcia D, Simancas-Racines D, et al. False-negative results of initial RT-PCR assays for COVID-19: a systematic review. PLos One 2020; 15(12): e0242958. Doi: 10.1371/journal.pone.0242958.
Hosseini AA, Shetty AK, Sprigg N, Auer DP, Constantinescu CS. Delirium as a presenting feature in COVID-19: neuroinvasive infection or autoimmune encephalopathy? Brain Behav Immun 2020; 88: 68-70. Doi: 10.1016/j.bbi.2020.06.012.
Downloads
Published
Issue
Section
License
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
How to Cite
